FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study-Prodige 14-ACCORD 21 (METHEP-2), a unicancer GI trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreFOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study-Prodige 14-ACCORD 21 (METHEP-2), a unicancer GI trial.
Type de publicationJournal Article
Year of Publication2016
AuteursYchou M, Rivoire M, Thezenas S, Guimbaud R, Ghiringhelli F, Mercier-Blas A, Mineur L, Francois E, Khemissa F, Moussata D, Becouarn Y, Houyau P, Aparicio T, Adam R, Galais M-P, Audemar F, Assenat E, Stanbury T, Bouche O
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.3512